257 related articles for article (PubMed ID: 22584436)
1. Inflammatory breast cancer: what we know and what we need to learn.
Yamauchi H; Woodward WA; Valero V; Alvarez RH; Lucci A; Buchholz TA; Iwamoto T; Krishnamurthy S; Yang W; Reuben JM; Hortobágyi GN; Ueno NT
Oncologist; 2012; 17(7):891-9. PubMed ID: 22584436
[TBL] [Abstract][Full Text] [Related]
2. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.
Yeh ED; Jacene HA; Bellon JR; Nakhlis F; Birdwell RL; Georgian-Smith D; Giess CS; Hirshfield-Bartek J; Overmoyer B; Van den Abbeele AD
Radiographics; 2013; 33(7):2003-17. PubMed ID: 24224593
[TBL] [Abstract][Full Text] [Related]
3. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
[TBL] [Abstract][Full Text] [Related]
4. Tailoring Treatment for Patients with Inflammatory Breast Cancer.
Newman AB; Lynce F
Curr Treat Options Oncol; 2023 Jun; 24(6):580-593. PubMed ID: 37043118
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory breast cancer: As surgical oncologists, what can we do?
Bouzaiene H; Saadallah F; Bouaziz H; Jaidane O; Ben Hassouna J; Dhieb T; Rahal K
Int Rev Cell Mol Biol; 2024; 384():113-124. PubMed ID: 38637095
[TBL] [Abstract][Full Text] [Related]
6. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory breast cancer: the disease, the biology, the treatment.
Robertson FM; Bondy M; Yang W; Yamauchi H; Wiggins S; Kamrudin S; Krishnamurthy S; Le-Petross H; Bidaut L; Player AN; Barsky SH; Woodward WA; Buchholz T; Lucci A; Ueno NT; Cristofanilli M
CA Cancer J Clin; 2010; 60(6):351-75. PubMed ID: 20959401
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory breast cancer: an overview.
van Uden DJ; van Laarhoven HW; Westenberg AH; de Wilt JH; Blanken-Peeters CF
Crit Rev Oncol Hematol; 2015 Feb; 93(2):116-26. PubMed ID: 25459672
[TBL] [Abstract][Full Text] [Related]
9. Update on systemic treatment for newly diagnosed inflammatory breast cancer.
Chainitikun S; Saleem S; Lim B; Valero V; Ueno NT
J Adv Res; 2021 Mar; 29():1-12. PubMed ID: 33842000
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from an unusual case of inflammatory breast cancer.
Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
Jacene HA; Youn T; DiPiro PJ; Hu J; Cheng SC; Franchetti Y; Shah H; Bellon JR; Warren L; Schlosnagle E; Nakhlis F; Rosenbluth J; Yeh E; Overmoyer B;
Clin Breast Cancer; 2019 Apr; 19(2):146-155. PubMed ID: 30584057
[TBL] [Abstract][Full Text] [Related]
12. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement.
Hussain MM; Ashley G; Daniel S; Sachin J; Amy K; Doreen A; Sasha B; Roman S; Ko Un P
Clin Breast Cancer; 2023 Aug; 23(6):e354-e358. PubMed ID: 37301712
[TBL] [Abstract][Full Text] [Related]
14. Contemporary surgical management of inflammatory breast cancer: a narrative review.
Adesoye T; Irwin S; Sun SX; Lucci A; Teshome M
Chin Clin Oncol; 2021 Dec; 10(6):57. PubMed ID: 35016511
[TBL] [Abstract][Full Text] [Related]
15. Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.
Chainitikun S; Espinosa Fernandez JR; Long JP; Iwase T; Kida K; Wang X; Saleem S; Lim B; Valero V; Ueno NT
PLoS One; 2021; 16(4):e0250057. PubMed ID: 33861773
[TBL] [Abstract][Full Text] [Related]
16. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory breast cancer.
Dushkin H; Cristofanilli M
J Natl Compr Canc Netw; 2011 Feb; 9(2):233-40; quiz 241. PubMed ID: 21310844
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory breast cancer: what progress have we made?
Dawood S; Cristofanilli M
Oncology (Williston Park); 2011 Mar; 25(3):264-70, 273. PubMed ID: 21548470
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
[TBL] [Abstract][Full Text] [Related]
20. Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
Niikura N; Liu J; Costelloe CM; Palla SL; Madewell JE; Hayashi N; Yu TK; Tokuda Y; Theriault RL; Hortobagyi GN; Ueno NT
Oncologist; 2011; 16(6):772-82. PubMed ID: 21632453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
